Description
BLOOD PRODUCTS AND SERVICES IDIQ
Base award description: IGF::OT::IGF BLOOD PRODUCTS AND SERVICES IDIQ
Modification chain · 4 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-06-29+$0= $0
- Mod P000012018-01-25+$0= $0
- Mod P000022018-07-05+$0= $0
- Mod P000032019-08-31+$0= $0
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-06-29 | +$0 | $0 | IGF::OT::IGF BLOOD PRODUCTS AND SERVICES IDIQ |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2018-01-25 | +$0 | $0 | IGF::OT::IGF BLOOD PRODUCTS AND SERVICES IDIQ |
| Mod P00002· EXERCISE AN OPTION | 2018-07-05 | +$0 | $0 | IGF::OT::IGF BLOOD PRODUCTS AND SERVICES IDIQ |
| Mod P00003· EXERCISE AN OPTION | 2019-08-31 | +$0 | $0 | BLOOD PRODUCTS AND SERVICES IDIQ |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SCFJBJWLMXT6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25626D0050 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
| 36C25626N0450 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $324,605 | FY2026 |
| 36C25626N0432 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $245,189 | FY2026 |
| 36C25626N0069 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $135,008 | FY2026 |
| 36C25625N0652 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $162,292 | FY2025 |
| 36C25625N0007 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $307,339 | FY2025 |
Other recipients under 6505 from 256-NETWORK CONTRACT OFFICE 16 (36C256) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25626N0555 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $654,692 | FY2026 |
| 36C25626P0618 | HANGER PROSTHETICS & ORTHOTICS INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $15,119 | FY2026 |
| 36C25626N0492 | BAYER HEALTHCARE PHARMACEUTICALS INC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $386,860 | FY2026 |
| 36C25626N0469 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $396,000 | FY2026 |
| 36C25626N0461 | CARDINAL HEALTH 414, LLC | 256-NETWORK CONTRACT OFFICE 16 (36C256) | $271,226 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_IDV_VA25617D0111_3600 · retrieved 2026-09-26.